Argenx To Host Conference Call & Webcast To Report Second Quarter Business Update And Half Year 2017 Financial Results On August 24, 2017 Post author:Sam Post published:August 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017 Ex-Genentechers' Denali Scores $1B+ Alzheimer's Deal With Takeda January 4, 2018 Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017
<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017